{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:47:43Z","timestamp":1790819263473,"version":"4.1.0"},"reference-count":45,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2015,10,29]],"date-time":"2015-10-29T00:00:00Z","timestamp":1446076800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Fonds de la Recherche en Sant\u00e9 du Qu\u00e9bec"},{"name":"R\u00e9seau Qu\u00e9b\u00e9cois de Recherche sur l'Usage des M\u00e9dicaments"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacoepidemiology and Drug"],"published-print":{"date-parts":[[2015,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Purpose<\/jats:title><jats:p>Macrolides have been linked to the occurrence of congenital heart defects, but findings are inconsistent. We therefore aimed to estimate the risk of major congenital malformations (MCMs) after fetal exposure to macrolides, focusing on cardiac malformations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>From the Quebec Pregnancy Cohort (1998\u20132008), women exposed to a macrolide or penicillin in the first trimester and unexposed women were studied. There were 135\u2009859 pregnancies included; 914 were exposed to azithromycin, 734 to erythromycin, 686 to clarithromycin, and 9106 to penicillin during the first trimester. Cases of MCMs were identified within the first year of life.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>After adjusting for potential confounders, azithromycin (RR\u2009=\u20091.19, 95%CI: 0.98, 1.44; 120 exposed cases), erythromycin (RR\u2009=\u20090.96, 95%CI: 0.74, 1.24; 66 exposed cases) and clarithromycin use (RR\u2009=\u20091.12, 95%CI: 0.99, 1.42; 79 exposed cases) during the first trimester of pregnancy were not statistically significantly associated with the risk of MCMs; no associations were observed for cardiac malformations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>First trimester exposure to any of the macrolides was not associated with an increased risk of overall MCMs or cardiac malformations specifically. Copyright \u00a9 2015 John Wiley &amp; Sons, Ltd.<\/jats:p><\/jats:sec>","DOI":"10.1002\/pds.3900","type":"journal-article","created":{"date-parts":[[2015,10,29]],"date-time":"2015-10-29T19:42:48Z","timestamp":1446147768000},"page":"1241-1248","source":"Crossref","is-referenced-by-count":41,"title":["Use of macrolides during pregnancy and the risk of birth defects: a population\u2010based study"],"prefix":"10.1002","volume":"24","author":[{"given":"Anick","family":"B\u00e9rard","sequence":"first","affiliation":[{"name":"Research Center CHU Ste\u2010Justine  Montreal Quebec Canada"},{"name":"Faculty of Pharmacy University of Montreal  Montreal Quebec Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odile","family":"Sheehy","sequence":"additional","affiliation":[{"name":"Research Center CHU Ste\u2010Justine  Montreal Quebec Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin\u2010Ping","family":"Zhao","sequence":"additional","affiliation":[{"name":"Research Center CHU Ste\u2010Justine  Montreal Quebec Canada"},{"name":"Faculty of Pharmacy University of Montreal  Montreal Quebec Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedvig","family":"Nordeng","sequence":"additional","affiliation":[{"name":"PharmacoEpidemiology and Drug Safety Research Group, School of Pharmacy University of Oslo  Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,10,29]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2008.03102.x"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1269"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2004.04.025"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-2115(98)00138-9"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-004-0817-1"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.2159"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S16305"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq307"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2006.00927.x"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0056713"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/1751-486X.12023"},{"key":"e_1_2_10_13_1","first-page":"e460","article-title":"Trends in anti\u2010infective drugs use in pregnancy","volume":"19","author":"Santos F","year":"2012","journal-title":"J Popul Ther Clin Pharmacol"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpediatrics.2009.188"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1225"},{"key":"e_1_2_10_16_1","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0889-8545(21)00375-2","article-title":"The tetracyclines","volume":"19","author":"Egerman RS","year":"1992","journal-title":"Obstet Gynecol Clin N Am"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2005.01.010"},{"key":"e_1_2_10_18_1","unstructured":"The Swedish Medical Products Agency. [Erythromycin should be avoided in early pregnancy]2006[11 August 2014]. Available from:http:\/\/www.lakemedelsverket.se\/Alla\u2010nyheter\/NYHETER\u2010\u2010\u20102005\/Erytromycin\u2010bor\u2010undvikas\u2010under\u2010tidig\u2010graviditet\/."},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01691-12"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1080\/14767050500439657"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.2165\/11630920-000000000-00000"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2393-6-18"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.538"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2012.04286.x"},{"issue":"221","key":"e_1_2_10_25_1","first-page":"e1","article-title":"Safety of macrolides during pregnancy","volume":"208","author":"Lin KJ","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1558"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0093870"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2009.02377.x"},{"key":"e_1_2_10_29_1","volume-title":"Drugs in Pregnancy and Lactation","author":"Briggs GGFR","year":"2011"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3446"},{"key":"e_1_2_10_31_1","unstructured":"EUROCAT.European surveillance of congenital anomalies. [10\/10\/2014]. Available from:http:\/\/www.eurocat\u2010network.eu\/."},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwf215"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3016.2008.00978.x"},{"key":"e_1_2_10_34_1","first-page":"116","article-title":"Towards a drug concentration effect relationship for QT prolongation and torsades de pointes","volume":"5","author":"Webster R","year":"2002","journal-title":"Curr Opin Drug Discov Devel"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.302.1.320"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1027309703313"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1528-1157.2002.28999.x"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdrb.21107"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201402-0385CI"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2014.03.003"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/25.suppl_A.73"},{"key":"e_1_2_10_42_1","first-page":"505","article-title":"Clinical pharmacokinetics of azithromycin","volume":"43","author":"Singlas E","year":"1995","journal-title":"Pathol Biol (Paris)"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.20749"},{"key":"e_1_2_10_44_1","unstructured":"GervaisKJ IessaN B\u00e9rardA.Can we rely on pharmacy claims databases to ascertain maternal use of medications during pregnancy? PDS2014:Suppl;S34."},{"key":"e_1_2_10_45_1","first-page":"e360","article-title":"Validity of perinatal pharmacoepidemiologic studies using data from the RAMQ administrative database","volume":"16","author":"Berard A","year":"2009","journal-title":"Can J Clin Pharmacol"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.2005.00497.x"}],"container-title":["Pharmacoepidemiology and Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.3900","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.3900","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pds.3900","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T16:57:53Z","timestamp":1696352273000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pds.3900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,29]]},"references-count":45,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["10.1002\/pds.3900"],"URL":"https:\/\/doi.org\/10.1002\/pds.3900","archive":["Portico"],"relation":{},"ISSN":["1053-8569","1099-1557"],"issn-type":[{"value":"1053-8569","type":"print"},{"value":"1099-1557","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,29]]}}}